CanSino Biologics Inc. (FRA:CJH)
Germany · Delayed Price · Currency is EUR 3.916
-0.116 (-2.88%)
Last updated: Jan 28, 2026, 3:25 PM CET
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of €1.46 billion as of January 30, 2026. Its market cap has increased by 9.75% in one year.
Market Cap
1.46B
Enterprise Value
1.29B
Revenue
116.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.92
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 859.40M to 1.46B, an increase of 69.40%. That is a compound annual growth rate of 8.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 1.46B | 5.32% |
| Dec 31, 2025 | 1.38B | -4.25% |
| Dec 31, 2024 | 1.44B | -0.39% |
| Dec 29, 2023 | 1.45B | -56.39% |
| Dec 30, 2022 | 3.32B | -55.43% |
| Dec 31, 2021 | 7.45B | -4.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.50B |
| Mainova AG | 2.40B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.82B |
| tonies SE | 1.18B |
| Sedlmayr Grund und Immobilien AG | 983.95M |
| Berliner Effektengesellschaft AG | 886.48M |
| Northern Data AG | 815.94M |